Results 1 to 10 of about 201,604 (308)

SARS-CoV-2 Neutralization Assay System using Pseudo-lentivirus

open access: yesIndonesian Biomedical Journal, 2023
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects humans' lower respiratory tracts and causes coronavirus disease-2019 (COVID-19).
Anastasia Armimi   +9 more
doaj   +1 more source

Human Retrovirus Genomic RNA Packaging

open access: yesViruses, 2022
Two non-covalently linked copies of the retrovirus genome are specifically recruited to the site of virus particle assembly and packaged into released particles.
Heather M. Hanson   +3 more
doaj   +1 more source

The Battle between Retroviruses and APOBEC3 Genes: Its Past and Present

open access: yesViruses, 2021
The APOBEC3 family of proteins in mammals consists of cellular cytosine deaminases and well-known restriction factors against retroviruses, including lentiviruses.
Keiya Uriu   +3 more
doaj   +1 more source

Lentivirus Production [PDF]

open access: yesJournal of Visualized Experiments, 2009
RNA interference (RNAi) is a system of gene silencing in living cells. In RNAi, genes homologous in sequence to short interfering RNAs (siRNA) are silenced at the post-transcriptional state. Short hairpin RNAs, precursors to siRNA, can be expressed using lentivirus, allowing for RNAi in a variety of cell types.
Xiaoyin, Wang, Michael, McManus
openaire   +2 more sources

Fibrin-mediated lentivirus gene transfer: Implications for lentivirus microarrays [PDF]

open access: yesJournal of Controlled Release, 2010
We employed fibrin hydrogel as a bioactive matrix for lentivirus mediated gene transfer. Fibrin-mediated gene transfer was highly efficient and exhibited strong dependence on fibrinogen concentration. Efficient gene transfer was achieved with fibrinogen concentration between 3.75 and 7.5mg/ml.
Shruti D, Raut   +3 more
openaire   +2 more sources

Identification of a small molecule for enhancing lentiviral transduction of T cells

open access: yesMolecular Therapy: Methods & Clinical Development, 2023
Genetic modification of cells using viral vectors has shown huge therapeutic benefit in multiple diseases. However, inefficient transduction contributes to the high cost of these therapies.
Paulina Malach   +10 more
doaj   +1 more source

A human surfactant B deficiency air-liquid interface cell culture model suitable for gene therapy applications

open access: yesMolecular Therapy: Methods & Clinical Development, 2021
Surfactant protein B (SPB) deficiency is a severe monogenic interstitial lung disorder that leads to loss of life in infants as a result of alveolar collapse and respiratory distress syndrome.
Altar M. Munis   +2 more
doaj   +1 more source

Lentivirus malih preživača

open access: yesVeterinarska stanica, 2023
Small ruminant lentivirus (SRLV) is a group of viruses of the Retroviridae family, shared between caprine, ovine and wild ruminants. It is responsible for a systemic infection that can affect the lungs, central nervous system, mammary gland and joints, causing chronic, insidious, and progressive diseases, seriously affecting animal health. Concurrently,
Jacob_Ferreira, João   +7 more
openaire   +3 more sources

Gene Therapy Applications of Non-Human Lentiviral Vectors

open access: yesViruses, 2020
Recent commercialization of lentiviral vector (LV)-based cell therapies and successful reports of clinical studies have demonstrated the untapped potential of LVs to treat diseases and benefit patients. LVs hold notable and inherent advantages over other
Altar M. Munis
doaj   +1 more source

The Late Asymptomatic and Terminal Immunodeficiency Phases in Experimentally FIV-Infected Cats—A Long-Term Study

open access: yesViruses, 2023
Feline immunodeficiency virus (FIV) is a lentivirus in the family Retroviridae that infects domestic cats resulting in an immunodeficiency disease featuring a progressive and profound decline in multiple sets of peripheral lymphocytes. Despite compelling
Brian G. Murphy   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy